Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.75%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$38.8B
AUM Growth
-$1.01B
(-2.5%)
Cap. Flow
-$4.03B
Cap. Flow
% of AUM
-10.37%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
3,658
New
595
Increased
588
Reduced
695
Closed
822
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$311M |
| 2 |
Biogen
BIIB
|
+$303M |
| 3 |
Nike
NKE
|
+$268M |
| 4 |
Alibaba
BABA
|
+$261M |
| 5 |
Citigroup
C
|
+$252M |
Top Sells
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$319M |
| 3 |
JPMorgan Chase
JPM
|
+$301M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$232M |
| 5 |
Boston Scientific
BSX
|
+$197M |
Sector Composition
| 1 | Financials | 17.87% |
| 2 | Healthcare | 17.83% |
| 3 | Technology | 16.43% |
| 4 | Consumer Discretionary | 15.13% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Boyd Gaming
BYD
$6.79B
| $256K | ﹤0.01% |
4,700
-42,600
| -90% | -$2.32M |
|
2002
Stratasys
SSYS
$835M
| $256K | ﹤0.01% |
21,585
-4,700
| -18% | -$55.7K |
|
2003
Dyne Therapeutics
DYN
$1.87B
| $256K | ﹤0.01% |
22,052
-42,858
| -66% | -$497K |
|
2004
Fox Factory Holding Corp
FOXF
$1.14B
| $255K | ﹤0.01% |
+2,800
| New | +$255K |
|
2005
NETGEAR
NTGR
$831M
| $254K | ﹤0.01% |
+14,000
| New | +$254K |
|
2006
First Trust Nasdaq Oil & Gas ETF
FTXN
$117M
| $254K | ﹤0.01% |
9,067
-233
| -3% | -$6.52K |
|
2007
Blue Owl Capital
OWL
$12.2B
| $253K | ﹤0.01% |
+23,900
| New | +$253K |
|
|
VLRS
2008
Controladora Vuela Compañía de Aviación
VLRS
$694M
| $251K | ﹤0.01% |
30,018
-37,996
| -56% | -$318K |
|
2009
Colgate-Palmolive
CL
$67.3B
| $250K | ﹤0.01% |
3,178
-559,898
| -99% | -$44.1M |
|
2010
Bio-Rad Laboratories Class A
BIO
$7.59B
| $250K | ﹤0.01% |
595
-172,005
| -100% | -$72.3M |
|
2011
Everspin Technologies
MRAM
$154M
| $250K | ﹤0.01% |
44,992
-2,679
| -6% | -$14.9K |
|
2012
West Pharmaceutical
WST
$18.2B
| $249K | ﹤0.01% |
1,056
-112,121
| -99% | -$26.4M |
|
2013
Rapid7
RPD
$1.27B
| $248K | ﹤0.01% |
+7,300
| New | +$248K |
|
2014
SAP
SAP
$299B
| $248K | ﹤0.01% |
2,400
-106,878
| -98% | -$11M |
|
2015
Stellar Bancorp
STEL
$1.61B
| $247K | ﹤0.01% |
8,389
+510
| +6% | +$15K |
|
2016
Xperi
XPER
$279M
| $247K | ﹤0.01% |
+28,700
| New | +$247K |
|
2017
Alight
ALIT
$1.95B
| $247K | ﹤0.01% |
29,500
-28,400
| -49% | -$237K |
|
2018
Cannae Holdings
CNNE
$1.11B
| $246K | ﹤0.01% |
+11,892
| New | +$246K |
|
|
UROY
2019
Uranium Royalty Corp
UROY
$420M
| $246K | ﹤0.01% |
+103,606
| New | +$246K |
|
2020
UWM Holdings
UWMC
$1.5B
| $245K | ﹤0.01% |
74,079
-71,557
| -49% | -$237K |
|
2021
Metropolitan Bank Holding Corp
MCB
$807M
| $243K | ﹤0.01% |
4,150
-48,991
| -92% | -$2.87M |
|
2022
Pacer Industrial Real Estate ETF
INDS
$125M
| $243K | ﹤0.01% |
+6,606
| New | +$243K |
|
2023
American Electric Power
AEP
$58.5B
| $243K | ﹤0.01% |
2,559
-37,680
| -94% | -$3.58M |
|
|
TARO
2024
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $242K | ﹤0.01% |
8,348
-835
| -9% | -$24.2K |
|
2025
Globalstar
GSAT
$3.79B
| $242K | ﹤0.01% |
12,140
-30,700
| -72% | -$612K |
|